Select a medication above to begin.
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
coagulation factor Xa (recombinant), inactivated
Black Box Warnings .
Thromboembolic and Ischemic Events, Cardiac Arrest, and Sudden Deaths
serious and life-threatening arterial and venous thromboembolic events, ischemic events, including MI and ischemic stroke, cardiac arrest, and sudden deaths have occurred; monitor for thromboembolic events and initiate anticoagulation when medically appropriate; monitor for signs/symptoms preceding cardiac arrest and tx as needed
Adult Dosing .
Dosage forms: INJ
Withdrawn from US Market
- [December 22, 2025]
- Info: voluntarily withdrawn due to reported serious and fatal thromboembolic events and risk/benefit ratio
Peds Dosing .
- Dosage forms: --
Withdrawn from US Market
- [December 22, 2025]
- Info: voluntarily withdrawn due to reported serious and fatal thromboembolic events and risk/benefit ratio